Xinfeng Yan
Shanghai East Hospital(CN)Shandong First Medical University(CN)
Publications by Year
Research Areas
Advanced Glycation End Products research, Cardiovascular Health and Risk Factors, Health Promotion and Cardiovascular Prevention, Diabetes, Cardiovascular Risks, and Lipoproteins, Gut microbiota and health
Most-Cited Works
- → Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment(2016)157 cited
- → Ultrasensitive sensors reveal the spatiotemporal landscape of lactate metabolism in physiology and disease(2022)123 cited
- → Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study(2016)108 cited
- → Effects of mobile phone application combined with or without self‐monitoring of blood glucose on glycemic control in patients with diabetes: A randomized controlled trial(2019)65 cited
- → CARD 9 mutation linked to Corynespora cassiicola infection in a Chinese patient(2015)62 cited
- → AGE/RAGE-Induced EMP Release via the NOX-Derived ROS Pathway(2018)58 cited
- → The Protective Effects of α-Lipoic Acid on Kidneys in Type 2 Diabetic Goto-Kakisaki Rats via Reducing Oxidative Stress(2013)54 cited
- → Association between circulating oxidized OxLDL/LDL-C ratio and the severity of coronary atherosclerosis, along with other emerging biomarkers of cardiovascular disease in patients with type 2 diabetes(2022)42 cited
- → Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products(2011)40 cited
- Vitamin D-binding protein (group-specific component) has decreased expression in rheumatoid arthritis.(2012)